Ewing's sarcoma: a miracle drug waiting to happen?
Robert
R
Longtin
D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000532:radiotherapy; D002880:Chromosomes, Human, Pair 11; D002892:Chromosomes, Human, Pair 22; D004345:Drug Industry / Q000639:trends; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects*; D006801:Humans; D015514:Oncogene Proteins, Fusion / Q000187:drug effects* / Q000235:genetics*; D011379:Prognosis; D051789:Proto-Oncogene Protein c-fli-1; D034802:RNA-Binding Protein EWS; D012512:Sarcoma, Ewing / Q000188:drug therapy* / Q000235:genetics / Q000532:radiotherapy; D014157:Transcription Factors / Q000187:drug effects* / Q000235:genetics*; D014178:Translocation, Genetic / Q000187:drug effects
D000970:Antineoplastic Agents; C106031:EWS-FLI fusion protein; D015514:Oncogene Proteins, Fusion; D051789:Proto-Oncogene Protein c-fli-1; D034802:RNA-Binding Protein EWS; D014157:Transcription Factors